EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Impact of Intermittent Preventive Treatment for Malaria in Pregnancy With Sulfadoxine-Pyrimethamine, Dihydroartemisinin-Piperaquine, and Their Combination on Infant Outcomes: A Randomized Controlled Trial

Joaniter I Nankabirwa iD, Abel Kakuru iD, Anna T Nguyen iD, Michelle E Roh, Miriam Aguti iD, Harriet Adrama, Jimmy Kizza, Peter Olwoch iD, Kylie Camanag iD, Jade Benjamin-Chung iD, Philip J Rosenthal, Moses R Kamya und 2 weitere

Clinical Infectious Diseases · 28.10.2026 · 83 (4) · e757-e765

DOI: 10.1093/cid/ciag253 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Infectious Diseases, online erschienen am 20.04.2026. Verfasst von Joaniter I Nankabirwa und 13 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Research Collaboration (IDRC), Kampala, Uganda. Hauptthemen laut MEDLINE: Pyrimethamine, Sulfadoxine, Artemisinins, Antimalarials. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Bill & Melinda Gates Foundation, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Intermittent preventive treatment in pregnancy (IPTp) with dihydroartemisinin-piperaquine (IPTp-DP) is more effective than sulfadoxine-pyrimethamine (IPTp-SP) at reducing the burden of malaria in pregnancy. Paradoxically, IPTp-DP has been associated with lower birth weights compared with IPTp-SP. Whether the impacts of IPTp-DP extend after birth is unknown.

Methods

We conducted a double-blind randomized controlled trial to compare malaria burden and growth among infants born to mothers who were randomized to monthly IPTp-SP, IPTp-DP, or IPTp-DP + SP. Infants were followed to 12 months of age by passive and active surveillance. The primary outcome was clinical malaria incidence; secondary outcomes included parasite prevalence and infant growth outcomes.

Results

Among 871 infants enrolled, there were 667 episodes of clinical malaria. Compared to infants whose mothers received IPTp-SP, malaria incidence was similar in infants whose mothers received IPTp-DP (incidence rate ratio [IRR] 1.04, 95% CI .78–1.38) or IPTp-DP + SP (IRR = 0.93, 95% CI .68–1.26). Overall parasite prevalence at monthly visits was 21.8%. Parasite prevalence was also similar between groups. The prevalence of wasting at birth was higher in infants whose mothers received IPTp-DP + SP (prevalence ratio [PR] = 2.30, 95% CI 1.07–4.97) or IPTp-DP (PR = 2.25, 95% CI 1.03–4.94) than those that received IPTp-SP, but differences between groups resolved by 3–6 months of age.

Conclusions

There were no significant differences in infant outcomes between the 3 IPTp arms apart from a transiently increased risk of wasting among infants born to mothers who received DP-containing IPTp regimens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyrimethamineSulfadoxineArtemisininsAntimalarialsQuinolinesMalariaPregnancy Complications, ParasiticHumansFemalePregnancyDrug CombinationsPiperazinesInfantAdultDouble-Blind MethodTreatment OutcomeInfant, NewbornIncidenceDrug Therapy, CombinationYoung AdultMaleChemoprevention

Stichwörter der Autor:innen

chemopreventioninfant outcomesmalariapregnancy

Substanzen

PyrimethamineSulfadoxineartenimolpiperaquineArtemisininsAntimalarialsDrug Combinationsfanasil, pyrimethamine drug combinationPiperazinesQuinolines

Autor:innen und Institutionen

  • Infectious Diseases Research Collaboration (IDRC), Kampala, Uganda.
  • Department of Internal Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
  • Department of Medicine (Infectious Diseases), Stanford University, California, USA.
  • Department of Medicine, University of California SanFrancisco, California, USA.

ORCID-Profile: Joaniter I Nankabirwa, Abel Kakuru, Anna T Nguyen, Miriam Aguti, Peter Olwoch, Kylie Camanag, Jade Benjamin-Chung, Grant Dorsey, Prasanna Jagannathan

Förderung

  • Bill & Melinda Gates Foundation
  • NIAID NIH HHS

Zitieren

APA

Nankabirwa, J. I., Kakuru, A., Nguyen, A. T., Roh, M. E., Aguti, M., Adrama, H., Kizza, J., Olwoch, P., Camanag, K., Benjamin-Chung, J., Rosenthal, P. J., Kamya, M. R., Dorsey, G., & Jagannathan, P. (2026). Impact of Intermittent Preventive Treatment for Malaria in Pregnancy With Sulfadoxine-Pyrimethamine, Dihydroartemisinin-Piperaquine, and Their Combination on Infant Outcomes: A Randomized Controlled Trial. Clinical Infectious Diseases, 83(4), e757-e765. https://doi.org/10.1093/cid/ciag253

Vancouver

Nankabirwa JI, Kakuru A, Nguyen AT, Roh ME, Aguti M, Adrama H, et al. Impact of Intermittent Preventive Treatment for Malaria in Pregnancy With Sulfadoxine-Pyrimethamine, Dihydroartemisinin-Piperaquine, and Their Combination on Infant Outcomes: A Randomized Controlled Trial. Clinical Infectious Diseases. 2026;83(4):e757-e765. doi:10.1093/cid/ciag253

BibTeX
@article{Nankabirwa2026,
  author = {Nankabirwa, Joaniter I and Kakuru, Abel and Nguyen, Anna T and Roh, Michelle E and Aguti, Miriam and Adrama, Harriet and Kizza, Jimmy and Olwoch, Peter and Camanag, Kylie and Benjamin-Chung, Jade and Rosenthal, Philip J and Kamya, Moses R and Dorsey, Grant and Jagannathan, Prasanna},
  title = {Impact of Intermittent Preventive Treatment for Malaria in Pregnancy With Sulfadoxine-Pyrimethamine, Dihydroartemisinin-Piperaquine, and Their Combination on Infant Outcomes: A Randomized Controlled Trial},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  volume = {83},
  number = {4},
  pages = {e757--e765},
  doi = {10.1093/cid/ciag253}
}
Kostenlos starten →